Inventor · disambiguated record
David M. Jablons
Also filed as: JABLONS DAVID · JABLONS DAVID M
24 granted patents·15 pending applications·77 citations·filing 2002–2024
94Inventor score
Top patents by PatentIndex Score
39 records- 0190US7959923B2Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNAUNIV CALIFORNIA·Filed 2009·Granted Jun 14, 2011·16 cites·15 claims
- 0289US7714014B2Targeting GLI proteins in human cancer by small moleculesUNIV CALIFORNIA·Filed 2006·Granted May 11, 2010·18 cites·16 claims
- 0388US2025075274A1Multigene prognostic assay for lung cancerUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0483US11072600B2Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancerUNIV CALIFORNIA·Filed 2017·Granted Jul 27, 2021·2 cites·42 claims
- 0583US10562886B2Anti-cancer compoundsUNIV CALIFORNIA·Filed 2016·Granted Feb 18, 2020·2 cites·39 claims
- 0682US11149025B2Anti-cancer compoundsUNIV CALIFORNIA·Filed 2020·Granted Oct 19, 2021·1 cites·18 claims
- 0782US7601750B2Small molecule inhibition of a PDZ-domain interactionUNIV CALIFORNIA·Filed 2006·Granted Oct 13, 2009·4 cites·25 claims
- 0879US11560356B2Compounds and compositions for the treatment of cancerUNIV CALIFORNIA·Filed 2017·Granted Jan 24, 2023·2 cites·24 claims
- 0978US2020377957A1Multigene prognostic assay for lung cancerUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1078US2022195532A1Multigene prognostic assay for lung cancerUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1176US8450062B2SOCS-3 promoter methylation in cancerHE BIAO·Filed 2010·Granted May 28, 2013·1 cites·4 claims
- 1275US7795295B2Small molecule inhibition of PDZ-domain interactionUNIV CALIFORNIA·Filed 2005·Granted Sep 14, 2010·2 cites·44 claims
- 1375US7141600B2Small molecule inhibition of a PDZ-domain interactionUNIV CALIFORNIA·Filed 2004·Granted Nov 28, 2006·7 cites·18 claims
- 1474US11708352B2Anti-cancer compoundsUNIV CALIFORNIA·Filed 2021·Granted Jul 25, 2023·0 cites·19 claims
- 1573US9840470B2Targeting GLI proteins in human cancer by small moleculesUNIV CALIFORNIA·Filed 2014·Granted Dec 12, 2017·2 cites·17 claims
- 1673US2010240035A1Multigene prognostic assay for lung cancerUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 1772US12145925B2Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancerUNIV CALIFORNIA·Filed 2021·Granted Nov 19, 2024·0 cites·33 claims
- 1872US9370521B2Targeting GLI proteins in human cancer by small moleculesHE BIAO·Filed 2012·Granted Jun 21, 2016·2 cites·23 claims
- 1970US10640493B2Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancerUNIV CALIFORNIA·Filed 2019·Granted May 5, 2020·0 cites·4 claims
- 2069US12227482B2Compounds and compositions for the treatment of cancerUNIV CALIFORNIA·Filed 2022·Granted Feb 18, 2025·0 cites·27 claims
- 2169US9133524B2Protein kinase ck2 gene mutations, amplifications and polymorphisms in human cancers and methods of useYOU LIANG·Filed 2011·Granted Sep 15, 2015·1 cites·14 claims
- 2269US2013123130A1Multigene prognostic assay for lung cancerUNIV CALIFORNIA·Filed 2012·Application pending·0 cites
- 2368US2018002761A1Multigene prognostic assay for lung cancerUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
- 2467US8211934B2Small molecule inhibition of PDZ-domain interactionGUY RODNEY KIPLIN·Filed 2010·Granted Jul 3, 2012·1 cites·33 claims
- 2565US2007037157A1Socs-3 promoter methylation in cancerUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 2663US2013273534A1Socs-3 promoter methylation in cancerUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 2762USD832713SMilk bottleCAL PHRESH LLC·Filed 2016·Granted Nov 6, 2018·14 cites·1 claims
- 2861US9476098B2Multigene prognostic assay for lung cancerMANN MICHAEL J·Filed 2012·Granted Oct 25, 2016·2 cites·35 claims
- 2959US2009304695A1Methods for treating cancer by inhibiting wnt signalingUNIV CALIFORNIA·Filed 2009·Application pending·0 cites
- 3057US2004247593A1Methods for treating cancer by inhibiting Wnt signalingUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 3149US11932606B2Anti-cancer/anti-fibrosis compoundsUNIV CALIFORNIA·Filed 2018·Granted Mar 19, 2024·0 cites·13 claims
- 3249US7618936B2Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)UNIV CALIFORNIA·Filed 2005·Granted Nov 17, 2009·0 cites·41 claims
- 3349US2003104432A1Methods of amplifying sense strand RNAUNIV CALIFORNIA·Filed 2002·Application pending·0 cites
- 3448US2011319337A1Dominant Negative WNT2 Compositions and Methods of UseBRAVO DAWN·Filed 2009·Application pending·0 cites
- 3548US2006040883A1Methods for treating cancer using anti-Wnt2 monoclonal antibodies and siRNAUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 3647US11479601B2Antibodies specific to Sonic Hedgehog and method of use thereofUNIV CALIFORNIA·Filed 2017·Granted Oct 25, 2022·0 cites·40 claims
- 3742US9279157B2EMX2 in cancer diagnosis and prognosisHE BIAO·Filed 2010·Granted Mar 8, 2016·0 cites·22 claims
- 3840US2008267951A1Methods for Treating Cancer Using Agents That Inhibit Wnt16 SignalingREGETS OF THE UNIVERSITY OF CA·Filed 2005·Application pending·0 cites
- 3935US2016098516A1Methods and systems for detection of a genetic mutationUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David M. Jablons files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →